FAST vs FDMT · P/E 43, rev $7.55B vs rev $37.0K
Fastenal Company (FAST) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the FAST and FDMT stock pages for the full models.
Not investment advice.